[1] |
AL MAMUN M, RUMANA N, KITA Y, et al. Combining the effects of conventional risk factors and environmental triggering factors while studying seasonality in acute myocardial infarction[J]. Environ Pollut, 2014, 189:252-253. DOI: 10.1016/j.envpol.2014.03.012.
|
[2] |
关天俊.慢性肾脏病与急性心肌梗死[J].肾脏病与透析肾移植杂志, 2014, 23(4):351-352. https://www.cnki.com.cn/Article/CJFDTOTAL-SZBY201404010.htmGUANG TJ. Chronic kidney disease and acute myocardial infarction[J].Chin J Nephrol Dial Transplant, 2014, 23(4):351-352. https://www.cnki.com.cn/Article/CJFDTOTAL-SZBY201404010.htm
|
[3] |
ZANCHETTI A, THOMOPOULOS C, PARATI G. Randomized controlled trials of blood pressure lowering in hypertension: a critical reappraisal[J]. Circ Res, 2015, 116(6):1058-1073. DOI: 10.1161/CIRCRESAHA. 116.303641.
|
[4] |
FISHMAN JA. Infection in organ transplantation[J]. Am J Transplant, 2017, 17(4):856-879. DOI: 10.1111/ajt.14208.
|
[5] |
ZHANG H, WANG K, CHEN H, et al. The double-edged sword of immunosuppressive therapy in kidney transplantation: a rare case report of pulmonary mucormycosis post-transplant and literature review[J]. Front Med (Lausanne), 2020, 7:500. DOI: 10.3389/fmed.2020.00500.
|
[6] |
陆再英, 钟南山.内科学[M].第7版.北京:人民卫生出版社, 2011:284.
|
[7] |
POMOZOVA TP, LYKOV YV, KOMAROVA IS, et al. Clinical and laboratory features of primary acute myocardial infarction in patients with obstructive and non-obstructive coronary atherosclerosis[J]. Kardiologiia, 2019, 59(10S):41-51. DOI: 10.18087/cardio.2640.
|
[8] |
国家心血管病中心.中国心血管病报告2016[M].北京:中国大百科全书出版社, 2017.
|
[9] |
中华医学会心血管病学分会心力衰竭学组, 中国医师协会心力衰竭专业委员会, 中华心血管病杂志编辑委员会.中国心力衰竭诊断和治疗指南2018[J].中华心血管病杂志, 2018, 46(10):760-789. DOI: 10.3760/cma.j.issn.0253-3758.2018.10.004.Heart Failure Group of Branch of Cardiovascular Medicine of Chinese Medical Association, Heart Failure Professional Committee of Chinese Medical Doctor Association, Editorial Committee of Chinese Journal of Cardiology. Chinese guidelines for the diagnosis and treatment of heart failure (2018)[J]. Chin J Cardiol, 2018, 46(10):760-789. DOI: 10.3760/cma.j.issn.0253-3758.2018.10.004.
|
[10] |
ZHANG Y, ZHANG J, BUTLER J, et al. Contemporary epidemiology, management, and outcomes of patients hospitalized for heart failure in China: results from the China Heart Failure (China-HF) Registry[J]. J Card Fail, 2017, 23(12):868-875. DOI: 10.1016/j.cardfail.2017.09.014.
|
[11] |
KRZYSZTOFIK JM, SOKOLSKI M, KOSOWSKI M, et al. Acute heart failure in patients admitted to the emergency department with acute myocardial infarction[J]. Kardiol Pol, 2017, 75(4):306-315. DOI: 10.5603/KP.a2016.0178.
|
[12] |
URIOL RIVERA MG, CABELLO PELEGRIN S, BALLESTER RUIZ C, et al. Impact of a multidisciplinary team for the management of thrombotic microangiopathy[J]. PLoS One, 2018, 13(11):e0206558. DOI: 10.1371/journal.pone.0206558.
|
[13] |
LU J, JIANG Y, QIAN M, et al. The improved effects of a multidisciplinary team on the survival of breast cancer patients: experiences from China[J]. Int J Environ Res Public Health, 2019, 17(1):277. DOI: 10.3390/ijerph17010277.
|
[14] |
PACKER M, O'CONNOR C, MCMURRAY JJV, et al. Effect of ularitide on cardiovascular mortality in acute heart failure[J]. N Engl J Med, 2017, 376(20):1956-1964. DOI: 10.1056/NEJMoa1601895.
|
[15] |
王紫晨, 谭静, 何婧瑜, 等.乌拉地尔和硝酸甘油治疗老年高血压合并心房颤动患者急性左心功能衰竭的效果[J].中国心血管杂志, 2016, 21(3):33-38. DOI:10. 3969/j.issn.1007-5410.2016.03.007.WANG ZC, TAN J, HE JY, et al. Therapeutic effects of urapidil and nitroglycerin for treatment of hypertension and atrial fibrillation in elderly patients with acute heart failure[J]. Chin J Cardiovasc Med, 2016, 21(3):33-38. DOI: 10.3969/j.issn.1007-5410.2016.03.007.
|
[16] |
张安吉, 王婷, 张阿宁.新活素对老年急性失代偿期心力衰竭患者心功能及尿量的影响[J].中国老年学杂志, 2017, 37(18):4533-4534. DOI:10.3969/j.issn.1005-9202. 2017.18.045.ZHANG AJ, WANG T, ZHANG AN. Effect of neovasin on cardiac function and urine output in elderly patients with acute decompensated heart failure[J]. Chin J Gerontol, 2017, 37(18):4533-4534. DOI:10.3969/j.issn. 1005-9202.2017.18.045.
|
[17] |
重组人脑利钠肽多中心研究协作组.重组人脑利钠肽治疗心力衰竭安全性和疗效的开放性随机对照多中心临床研究[J].中华心血管病杂志, 2011, 39(4):305-308. DOI: 10.3760/cma.j.issn.0253-3758.2011.04.005.Multicenter Clinical Study Group of Recombinant Human Brain Natriuretic Peptide. Efficacy and safety of recombinant human brain natriuretic peptide in heart failure: a multicenter, randomized, open label, controlled study[J]. Chin J Cardiol, 2011, 39(4):305-308. DOI: 10.3760/cma.j.issn.0253-3758.2011.04.005.
|
[18] |
WANG S, QU X, QU Y, et al. The effect of B-type brain natriuretic peptide on patients with acute decompensated heart failure coexisting with lung cancer: a randomized controlled clinical trial[J]. Pharmazie, 2014, 69(3):212-216.
|
[19] |
KHDER Y, SHI V, MCMURRAY JJV, et al. Sacubitril/valsartan (LCZ696) in heart failure[J]. Handb Exp Pharmacol, 2017, 243:133-165. DOI: 10.1007/164_2016_77.
|
[20] |
PFAU D, THORN SL, ZHANG J, et al. Angiotensin receptor neprilysin inhibitor attenuates myocardial remodeling and improves infarct perfusion in experimental heart failure[J]. Sci Rep, 2019, 9(1):5791. DOI: 10.1038/s41598-019-42113-0.
|
[21] |
张凯, 李广平.伊伐布雷定在心血管疾病中的应用进展[J].中国心血管杂志, 2017, 22(2):159-160, 封3. DOI: 10.3969/j.issn.1007-5410.2017.02.019.ZHANG K, LI GP. Progress in application of ivabradine in cardiovascular diseases[J]. Chin J Cardiovasc Med, 2017, 22(2):159-160, cover3. DOI:10.3969/j.issn.1007-5410. 2017.02.019.
|
[22] |
高晓飞, 许轶洲.伊伐布雷定在心血管疾病中的现状与进展[J].心血管病学进展, 2015, 36(3):346-348. DOI: 10.3969/j.issn.1004-3934.2015.03.029.GAO XF, XU YZ. The status and progress in using ivabradine in cardiovascular disease[J]. Adv Cardiovasc Dis, 2015, 36(3):346-348. DOI:10.3969/j.issn.1004-3934. 2015.03.029.
|
[23] |
时珊珊, 吴晓羽.伊伐布雷定在心血管疾病中的临床研究进展[J].中国循环杂志, 2015, 30(6):613-616. DOI: 10.3969/j.issn.1000-3614.2015.06.028.SHI SS, WU XY. Advances in the clinical study of ivabradine in cardiovascular disease[J]. Chin Circ J, 2015, 30(6):613-616. DOI: 10.3969/j.issn.1000-3614.2015.06.028.
|
[24] |
ZEYMER U, HOCHADEL M, KARCHER AK, et al. Procedural success rates and mortality in elderly patients with percutaneous coronary intervention for cardiogenic shock[J]. JACC Cardiovasc Interv, 2019, 12(18):1853-1859. DOI: 10.1016/j.jcin.2019.04.027.
|
[25] |
JI Z, ZHANG R, LU W, et al. The effect of nicorandil in patients with acute myocardial infarction undergoing percutaneous coronary intervention: a systematic review and Meta-analysis[J]. Ir J Med Sci, 2020, 189(1):119-131. DOI: 10.1007/s11845-019-02034-3.
|